CN Stock MarketDetailed Quotes
600535 Tasly Pharmaceutical Group
- 14.88
- -0.19-1.26%
Market Closed Dec 13 15:00 CST
22.23BMarket Cap25.22P/E (TTM)
15.16High14.86Low141.00KlotVolume15.08Open15.07Pre Close211.13MTurnover0.94%Turnover Ratio20.75P/E (Static)1.49BShares17.4452wk High1.82P/B22.23BFloat Cap11.9152wk Low16.58Limit Up1.49BShs Float38.06Historical High13.56Limit Down1.99%Amplitude-3.05Historical Low0.66Dividend TTM14.97Avg Price83.44KlotAsk4.44%Div YieldTTM100Lot Size55.36KlotBid
Tasly Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.53%7.06B | -2.05%4.94B | -22.32%1.72B | 7.64%10.37B | 5.72%7.32B | 12.05%5.05B | 13.84%2.21B | -3.30%9.64B | -9.39%6.92B | -16.38%4.5B |
| Refunds of taxes and levies | -82.62%3.37M | -48.36%2.95M | -20.25%518.63K | -42.15%17.59M | -39.68%19.37M | -76.80%5.72M | 1,713.95%650.34K | --30.42M | 6,716.91%32.11M | 6,175.98%24.66M |
| Cash received relating to other operating activities | -6.60%262.43M | -18.66%188.93M | -45.67%88.44M | -32.47%212.24M | 21.74%280.98M | 20.44%232.27M | 17.10%162.76M | 27.62%314.3M | -18.37%230.8M | -15.54%192.85M |
| Cash inflows from operating activities | -3.85%7.33B | -2.83%5.14B | -23.92%1.81B | 6.22%10.6B | 6.03%7.62B | 11.93%5.29B | 14.09%2.37B | -2.25%9.98B | -9.31%7.19B | -15.91%4.72B |
| Goods services cash paid | -15.03%1.68B | -11.32%1.18B | -14.66%566.51M | 12.16%2.24B | 16.92%1.98B | 15.33%1.33B | 22.27%663.87M | -0.06%2B | -5.30%1.69B | -5.44%1.15B |
| Staff behalf paid | -0.84%1.47B | -0.32%1B | -0.89%546.48M | 2.86%1.96B | 3.86%1.48B | 3.15%1.01B | 3.50%551.41M | 1.79%1.91B | -0.04%1.43B | -0.61%977.41M |
| All taxes paid | -15.38%764.95M | -10.97%562.45M | -16.93%266.2M | -1.78%1.12B | 5.81%903.97M | 10.79%631.78M | 20.92%320.47M | 12.80%1.14B | 11.94%854.36M | 12.17%570.26M |
| Cash paid relating to other operating activities | 2.56%2.22B | 1.88%1.5B | 11.03%763.72M | 1.79%2.7B | 1.64%2.16B | 5.59%1.48B | 4.77%687.84M | 5.15%2.66B | 14.21%2.13B | 10.75%1.4B |
| Cash outflows from operating activities | -6.03%6.14B | -4.39%4.25B | -3.63%2.14B | 4.22%8.03B | 6.98%6.53B | 8.47%4.44B | 11.33%2.22B | 3.93%7.7B | 4.46%6.1B | 3.16%4.1B |
| Net cash flows from operating activities | 9.22%1.19B | 5.43%886.71M | -324.05%-336.91M | 12.98%2.58B | 0.70%1.09B | 34.64%841.06M | 80.16%150.37M | -18.62%2.28B | -47.99%1.08B | -61.99%624.67M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 208.40%4.98B | 16.16%1.64B | -89.41%52.61M | -44.12%1.65B | 8.07%1.62B | 12.89%1.41B | 66.40%496.73M | 80.44%2.95B | 75.38%1.5B | 67.90%1.25B |
| Cash received from returns on investments | 11.98%35.18M | -20.98%18.38M | -40.31%5.21M | -49.52%31.17M | -38.59%31.42M | 29.38%23.26M | 9.47%8.73M | 8.79%61.75M | 3.55%51.16M | 28.86%17.97M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,728.98%9.76M | 40,729.33%9.34M | ---- | -11.30%1.19M | 36.62%533.61K | -92.85%22.87K | -98.17%2.12K | -98.05%1.34M | -99.39%390.57K | -99.49%320.02K |
| Cash received relating to other investing activities | 10.07%5.5M | 10.07%5.5M | --5.5M | 3,527.50%77.77M | --5M | --5M | ---- | 6.42%2.14M | ---- | ---- |
| Cash inflows from investing activities | 204.56%5.03B | 16.18%1.67B | -87.47%63.32M | -41.68%1.76B | 6.86%1.65B | 13.49%1.44B | 64.86%505.46M | 37.89%3.02B | 13.02%1.55B | 15.63%1.27B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -6.65%367.29M | -33.67%191.19M | -57.74%96.38M | 65.38%668.82M | 41.00%393.45M | 97.18%288.23M | 213.69%228.07M | -29.26%404.41M | -22.75%279.05M | -49.93%146.18M |
| Cash paid to acquire investments | 298.38%6.06B | 79.20%2.71B | -82.62%256.71M | -53.94%1.78B | -48.19%1.52B | -1.68%1.51B | 138.81%1.48B | 156.52%3.87B | 260.60%2.94B | 234.48%1.54B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | --30.94M | --30.94M | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | 1,912.41%102.8M | 54.69%7.9M | --5.87M | 20,124.77%1.42B | 6,421.84%5.11M | 6,421.84%5.11M | ---- | 233.33%7M | 339.90%78.33K | --78.33K |
| Cash outflows from investing activities | 234.79%6.53B | 58.41%2.91B | -78.95%358.96M | -9.68%3.87B | -39.33%1.95B | 9.03%1.84B | 146.66%1.71B | 92.02%4.28B | 143.10%3.22B | 87.38%1.69B |
| Net cash flows from investing activities | -402.13%-1.5B | -211.10%-1.24B | 75.36%-295.64M | -66.54%-2.11B | 82.12%-298.55M | 4.53%-398.04M | -211.84%-1.2B | -2,855.72%-1.27B | -3,782.29%-1.67B | -311.12%-416.91M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | -99.75%50K | ---- | ---- | ---- | 8.46%20M | 8.46%20M | 37.55%20M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | -99.75%50K | ---- | ---- | ---- | 8.46%20M | 8.46%20M | 37.55%20M |
| Cash from borrowing | -14.56%1.39B | -25.88%1.19B | -60.60%558.06M | -32.97%1.82B | -18.15%1.63B | 84.39%1.6B | 280.08%1.42B | 88.16%2.71B | 68.17%1.99B | -23.81%869.13M |
| Cash received relating to other financing activities | 202.37%1.81B | 1,108.39%1.81B | 1,197.34%1.36B | 214.30%323.07M | 20.00%600.1M | -69.97%150.16M | -79.00%105M | 834.45%102.79M | 4,900.61%500.06M | 4,900.61%500.06M |
| Cash inflows from financing activities | 43.82%3.21B | 71.30%3B | 26.22%1.92B | -24.47%2.14B | -11.20%2.23B | 26.17%1.75B | 74.33%1.52B | 92.75%2.83B | 107.12%2.51B | 19.22%1.39B |
| Borrowing repayment | 201.63%1.54B | 97.85%889.03M | 599.45%600M | -43.40%1.26B | -64.23%510.48M | -41.58%449.34M | -70.49%85.78M | -15.50%2.23B | -41.57%1.43B | -65.55%769.21M |
| Dividend interest payment | -3.01%527.43M | -2.16%516.89M | -36.15%12.84M | 1.70%563.39M | 0.60%543.82M | -0.37%528.29M | 4.23%20.12M | -13.53%553.97M | -12.85%540.6M | -12.42%530.26M |
| -Including:Cash payments for dividends or profit to minority shareholders | 79.55%300K | ---- | ---- | --167.08K | --167.08K | --167.08K | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 50.46%2.01B | 49.38%1.47B | 2.92%620.37M | 428.69%1.51B | 148.24%1.33B | 83.29%984.48M | 162.24%602.79M | -57.53%285.74M | 336.36%537.16M | 485.00%537.11M |
| Cash outflows from financing activities | 70.60%4.07B | 46.61%2.88B | 74.01%1.23B | 8.67%3.34B | -4.67%2.39B | 6.83%1.96B | 31.28%708.69M | -22.33%3.07B | -21.37%2.5B | -37.31%1.84B |
| Net cash flows from financing activities | -448.44%-866.68M | 160.10%125.85M | -15.46%687.06M | -405.59%-1.2B | -2,621.11%-158.03M | 53.20%-209.38M | 144.13%812.67M | 90.47%-236.63M | 100.32%6.27M | 74.65%-447.39M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -1,124.54%-917.35K | -18.40%615.95K | 104.10%143.06K | -104.16%-1.26M | -99.54%89.54K | -94.95%754.87K | -88.84%-3.49M | 1,468.25%30.39M | 487.79%19.6M | 418.91%14.95M |
| Net increase in cash and cash equivalents | -285.90%-1.18B | -196.04%-225.11M | 122.73%54.66M | -190.48%-730.54M | 212.61%633M | 204.33%234.4M | -910.64%-240.51M | 191.49%807.36M | -461.14%-562.12M | -383.40%-224.68M |
| Add:Begin period cash and cash equivalents | -24.92%2.2B | -24.95%2.2B | -24.75%2.2B | 38.07%2.93B | 38.13%2.93B | 38.18%2.93B | 38.08%2.92B | 16.03%2.12B | 15.94%2.12B | 15.94%2.12B |
| End period cash equivalent | -71.33%1.02B | -37.63%1.97B | -15.95%2.25B | -24.95%2.2B | 128.67%3.56B | 66.95%3.16B | 24.95%2.68B | 39.12%2.93B | -21.50%1.56B | -0.66%1.89B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
